MétaCan
Menu
Back to cohort
Record W4417258287 · doi:10.1016/j.lanogw.2025.100047

Experiences of women with ovarian cancer in 22 low-income and middle-income countries (Every Woman Study LMICs): a cross-sectional study

2025· article· en· W4417258287 on OpenAlexaff
Garth Funston, Eileen Morgan, Tracey L. Adams, Rafe Sadnan Adel, Carlos Eduardo Mattos Cunha Andrade, Raikhan Bolatbekova, Runcie C.W. Chidebe, S. Robin Cohen, Mary Eiken, Dilyara Kaidarova, Karen Kapur, Iren Lau, Clara Mackay, Precious Takondwa Makondi, Asima Mukhopadhyay, Aisha Mustapha, Sara Nasser, Florencia Noll, Martin Origa, Jitendra Pariyar, Shahana Pervin, Ngoc Phan, Rebeca Ramírez-Morales, Basel Refky, Juliana Rodríguez, Afrin Fatima Shaffi, Isabelle Soerjomataram, Eva-Maria Strömsholm, Sook‐Yee Yoon, Nargiza Zakhirova, Frances Reid, Federico Bianchi, A Boixart, Jeronimo Costa, M Dallochio, Julián Di Guilmi, Y Pablo Gola, Facundo Gutiérrez, Sergio Martin Lucchini, Mariano Rossini Rossini, J Saadi, Gasparini Soledad, Lara Vargas, Maria Victoria Vivas, Natalia P. Zeff, Glauco Baiocchi, Marina Muzeti, Rita Sousa, Audrey Tieko Tsunoda, Marcela Hernández, Trujillo Lina Maria, René Pareja, William D. Piñeros, Gabriel Jaime Rendón-Pereira, Erick Estuardo Estrada, Neerja Bhatla, Dona Chakraborty, Puja Chatterjee, Sandipan Chowdhuri, Rahul Roy Chowdhury, Bindiya Gupta, Nisha Singh, Priyanka Singh, Seema Singhal, Manisha Vernekar, Ian Bambury, Natalie Medley, Anna Kay Taylor-Christmas, Askar Aidarov, Arai Akkassova, Андреева О.Б., Gulnur Bagatov, Orynbassar Bertleuov, Dinara Imendinova, Dauren Kaldybek, Lyazzat Kozgamvayeva, Yerlan Kukubassov, E. Saparova, Aisulu Sarmenova, Alima Satanova, Zhandos Zhagniyev, Anisa Mburu, A. Hassan, Barbara Kadzakumanja, Akuzike Ntaula, Sandra Pemphero Chirombo, Claudia anak Richard Beginda, Martin Ho, Jamil Omar, Mohammed Mazniza'in Binti, Mahfooz Mohammed Bin, Rubandra Kumaar Kalimuthu, Thever AL Ramasamy Vickneswaren, Yin Ling Woo, Gunasagran Yogeeta, Chee Meng Yong, David Cantú de León, Mariana Villegas-Valenzuela, Sara Bendadi, Nada Benhima, Fatima-zahra Megzar, Poonam Lama, Pabitra Maharjan, Maya Neupane, Manju Pandy, Shashwat Pariyar, Madan Kumar Piya, Rashmey Pun, Ramesh Shrestha, Binuma Shrestha, Anisha Shrestha, Ramila Silkapar, Habiba Ibrahim Abdullahi, Maryam Ali, Joyce Asufi, Bala Mohammed Audu, Muhammad Dahiru, Onuh Gabriel Emmanuel, Michael Ezeanochie, Adegboyega A Fawole, Jamila Abubakar Garba, Umma Hani Ja’afaru, Asta Mana, Ramon Lawal Muhammed, Asmau Nasir, Christy Yilwada Ngwan, Chisom Nkemjika, Evaristus Oseiwe Oboh, Ameh Friday Ojonugwa, Sesan Oluwasola, Dimeji Oyerinde, Anna Peter, Musa Sahabi, Thomas Tsiterimam Sambo, Adesina Kikelomo Temilola, Uchenna Anthony Umeh, Chioma Roseline Umeh, Hadiza Abdullahi Usmanu, Aldo López Blanco, E. Centeno, Charles Chavez Chirinoz, Joan Perez, José Luis Zeballos, Jennifer Butt, Atisha Maharaji, Esther Mpamaani, Yiting Yu, Uchkun Abdukarimov, Juraeva Barno, Saide Djanklich, Avezova Mushtari, Mamukadze Shaira, Dilnoza Umaroma, Nguyễn Hương Giang, Do Vu Minh Ha, Tran Thanh Huong, Vo Van Kha, Nguyễn Thị Thùy Linh, Tran M. Ly, Phạm Thị Kiều Oanh, Tran Tu Quy, Trần Thị Như Quỳnh, Tran D. Tho, Dang Thanh Tung, Paul Kamfwa, Rachael Mawere, Susan Msadabwe, Mark F. Munsell

Bibliographic record

VenueThe Lancet Obstetrics Gynaecology & Women s Health · 2025
Typearticle
Languageen
FieldMedicine
TopicGlobal Cancer Incidence and Screening
Canadian institutionsOvarian Cancer Canada
Fundersnot available
KeywordsOvarian cancerMEDLINECancerDiseasePopulation

Abstract

fetched live from OpenAlex

Background Around 70% of ovarian cancers occur in low-income and middle-income countries (LMICs), but little is known about the experiences of women with ovarian cancer in this setting. We aimed to describe the experiences and priorities of women with ovarian cancer in LMICs, and to identify potentially modifiable factors linked to these experiences. Methods We did a cross-sectional, survey-based study in LMICs, recruiting women with ovarian cancer from 82 hospitals in 22 countries. Women diagnosed with ovarian cancer (primary malignancy of the ovary, fallopian tube, or peritoneum, including borderline tumours) at a study site within the past 5 years (2017–24), who were aged 18 years or older, were eligible for inclusion. Participants completed a 59-item survey at a single timepoint up to 5 years after their diagnosis, which collected information on demographics and cancer experiences. Survey data collection ran from June 14, 2022, to May 13, 2024. Data on cancer histology and stage at diagnosis were collected from medical records. Countries were grouped according to the four Human Development Index (HDI) levels (low, medium, high, and very high). The primary study outcomes were self-reported knowledge of ovarian cancer before diagnosis and the extent of any financial impact of having ovarian cancer. Based on survey responses, knowledge of ovarian cancer was ordered from low (had never heard of it) to high (had heard of it and knew something about it), and extent of financial impact from low (not at all) to high (a great extent). Random-effects ordered logistic regression was used to investigate the association of participant-reported variables and country HDI group with each primary outcome. Findings We analysed data from 2446 women with ovarian cancer (mean age at diagnosis 49·9 years [SD 13·6]). 631 (26·1%) of 2421 participants who reported on their knowledge of ovarian cancer before diagnosis reported that they had heard of ovarian cancer and knew something about it (range: three [3·3%] of 90 participants in Nepal to 92 [63·4%] of 145 in Uzbekistan). In multivariable regression analyses of 2133 participants with relevant data on model variables, lower education level (no formal education vs tertiary or higher education, odds ratio [OR] 3·41, 95% CI 2·38–4·89, p<0·0001; and primary or secondary education vs tertiary or higher education, OR 1·96, 1·56–2·47, p<0·0001), lower household income (self-perceived as below vs above average for the country, OR 1·79, 1·28–2·50, p=0·0006), and lower HDI group (low vs very high HDI group, OR 2·32, 1·06–5·04, p=0·034; and medium vs very high HDI group, OR 1·88, 1·04–3·42, p=0·038) were associated with a decrease in ovarian cancer knowledge by one category level. 1105 (45·9%) of 2406 participants who reported on the extent of financial impact of ovarian cancer indicated that their financial situation had been affected to a great extent (range: 16 [15·2%] of 105 in Argentina to 46 [83·6%] of 55 in Uganda). In multivariable regression analyses of 2099 participants, lower household income (self-perceived as below vs above average for the country, OR 3·64, 2·58–5·14, p<0·0001; and average vs above average for the country, OR 1·78, 1·31–2·41, p=0·0002) and lower HDI group (low vs very high HDI group, OR 3·70, 1·10–12·45, p=0·035; and medium vs very high HDI group, OR 3·47, 1·40–8·59, p=0·0072) were associated with an increase in financial impact by one category level. Interpretation We have identified factors associated with ovarian cancer knowledge, experiences, and outcomes across LMICs, which could inform policy and the development of interventions to improve patient care. Given variation in patient experiences and outcomes between LMICs, interventions should be tailored to local needs and priorities. Funding International Gynecologic Cancer Society and the World Ovarian Cancer Coalition.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.010
Threshold uncertainty score0.020

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0010.000
Scholarly communication0.0010.001
Open science0.0000.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.044
GPT teacher head0.363
Teacher spread0.318 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueThe Lancet Obstetrics Gynaecology & Women s HealthSame topicGlobal Cancer Incidence and ScreeningFrench-language works237,207